NCT00768963 Ranibizumab for the Inhibition of Neovascularization in Pterygia Status COMPLETED Phase PHASE1
NCT00765921 Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma Status COMPLETED Phase PHASE1
NCT00750399 Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma Status COMPLETED Phase PHASE1
NCT00749021 Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments Status COMPLETED Phase PHASE1
NCT00727753 VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD) Status COMPLETED Phase N/A
NCT00726973 Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) Status WITHDRAWN Phase NA
NCT00710229 Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration Status UNKNOWN Phase PHASE3
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study Status COMPLETED Phase PHASE3
NCT00685854 Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth Status COMPLETED Phase PHASE1
NCT00685503 Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth Status COMPLETED Phase PHASE1
NCT00681889 Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) Status COMPLETED Phase PHASE1
NCT00680498 Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment Status COMPLETED Phase PHASE4
NCT00676559 Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study Status WITHDRAWN Phase PHASE1
NCT00674323 Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy Status COMPLETED Phase PHASE4
NCT00668785 Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) Status TERMINATED Phase PHASE2
NCT00667472 Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks Status WITHDRAWN Phase PHASE1
NCT00661583 Use of Ranibizumab With Mitomycin C During Trabeculectomy Status COMPLETED Phase PHASE1/PHASE2
NCT00657202 Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1 Status COMPLETED Phase EARLY_PHASE1
NCT00644280 Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery Status TERMINATED Phase NA
NCT00640640 The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) Status UNKNOWN Phase NA